T2 Biosystems, Inc.
Formerly Bioplex Systems, Inc.
Funding rounds
0 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2016 | $40 M | Private placement after listing | $10 to $50 million | equity | SEC | |
| Mar 2013 | $400 M | Private placement after listing | $250 million to $1 billion | equity | SEC | |
| Aug 2011 | $23 M | Private placement after listing | $10 to $50 million | equity | SEC | |
| May 2010 | $15 M | Private placement after listing | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
T2 Biosystems, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2016).
SEC Form D · Sep 2016
The industry group it chose in its notices: Other Technology.
SEC Form D · Sep 2016
That is all the official record says: T2 Biosystems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
24 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Aisling Capital III LP | Fund or asset manager | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Aisling Capital Partners III LLC | Fund or asset manager | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Aisling Capital Partners III LP | Fund or asset manager | not stated | not stated | Held Series D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Bridge Street 2013 Holdings, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Bridge Street 2013, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Bridge Street 2013 Offshore, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Bridge Street Opportunity Advisors, L.L.C. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Broad Street Principal Investments, L.L.C. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Flagship Ventures Fund 2004 L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Flagship Ventures Fund IV General Partner LLC | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Flagship Ventures Fund IV, L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Flagship Ventures General Partner LLC | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Goldman Sachs & Co | Other | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Goldman Sachs Group Inc | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MBD 2013 Holdings, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MBD 2013, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MBD 2013 Offshore, L.P. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| MBD Advisors, L.L.C. | Fund or asset manager | not stated | not stated | Held Series E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Michael J. Cima | Person | not stated | not stated | Held Series E preferred stock, director (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Management Co. V, L.L.C. | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners Special Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
| Polaris Venture Partners V, L.P. | Venture capital | not stated | not stated | Held Series A-1, A-2, B, C, D and E preferred stock, 10% owner (Form 3, 2014) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David P. Harding | Chief Commercial Officer | Sep 2016 |
| Joanne Spadoro, Ph.D. | Chief Operating Officer | Sep 2016 |
| John McDonough | Chief Executive Officer | Sep 2016 |
| Michael A. Pfaller, M.D. | Chief Medical Officer | Sep 2016 |
| Michael M. Gibbs, Esq. | Vice President and General Counsel | Sep 2016 |
| Rahul M. Dhanda | Senior Vice President, Corporate Development | Sep 2016 |
| Shawn Lynch | Chief Financial Officer | Sep 2016 |
| Steven M. Scampini | Vice President, Engineering | Sep 2016 |
| Tom Lowery, Ph.D. | Chief Scientific Officer | Sep 2016 |
| Thomas Lowery | Executive officer | Mar 2013 |
| Jeffrey Wiesen | Executive officer | May 2010 |
| Adrian M. Jones | Director | Sep 2016 |
| David W. Elsbree | Director | Sep 2016 |
| John McDonough | Chief Executive Officer | Sep 2016 |
| John W. Cumming | Director | Sep 2016 |
| Josh A. Bilenker, M.D. | Director | Sep 2016 |
| Michael A. Cima, Ph.D. | Director | Sep 2016 |
| Seymour M. Liebman | Director | Sep 2016 |
| Stanley M. Lapidus | Director | Sep 2016 |
| Alan Crane | Director | Mar 2013 |
| Harry Wilcox | Director | Mar 2013 |
| Josh Bilenker | Director | Mar 2013 |
| Michael Cima | Director | Mar 2013 |
| Michael Greeley | Director | Mar 2013 |
| Robert Langer | Director | Mar 2013 |
| Stacy Feld | Director | Mar 2013 |
| Stan Lapidus | Director | Mar 2013 |
| TJ Carella | Director | Mar 2013 |
| Doug Levinson | Director | May 2010 |